Physician profile
Ashim V Kumar
NPI 1225052459
$1,208.39
in general payments reported to CMS, 2019-2025
9 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $32.15 · 2022: $131 · 2023: $76.33 · 2024: $239 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $323.03 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $264.70 | 2022-2025 | Menopur |
| Organon LLC | $246.20 | 2022-2025 | Ganirelix Acetate, Follistim Aq, Pregnyl |
| Abbvie INC. | $200.82 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $46.66 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $42.29 | 2022 | |
| Pfizer INC. | $34.87 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $33.33 | 2019 | |
| Cook Medical LLC | $16.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashim Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.